Milestone Notices Clause Samples
The Milestone Notices clause establishes the requirement for one party to formally notify the other when a specific project milestone has been achieved. Typically, this involves sending written confirmation that a deliverable or phase has been completed, which may trigger subsequent actions such as payment, review, or the commencement of the next project stage. This clause ensures clear communication and documentation of progress, helping to prevent disputes about project status and aligning both parties on the timeline and expectations.
Milestone Notices. Sanofi-aventis shall provide ImmunoGen with prompt written notice upon each occurrence of a milestone event set forth in Section 4.4.1. In the event that, notwithstanding the fact that sanofi-aventis has not given such a notice, ImmunoGen believes any such milestone event has occurred, it shall so notify sanofi-aventis in writing and shall provide to sanofi-aventis data, documentation or other information that supports its belief.
Milestone Notices. Unigene shall notify USL in writing of the achievement of each of the foregoing Milestones within *** (***) Business Days after such achievement.
Milestone Notices. Biotest shall provide ImmunoGen with prompt written notice upon each achievement of a milestone event set forth in Section 6.3.1, which notice shall include a description of the applicable milestone event. In the event that, notwithstanding the fact that Biotest has not given such a notice, ImmunoGen believes any such milestone event has occurred, it shall so notify Biotest in writing and shall provide to Biotest data, documentation or other information that supports its belief. Any dispute under this Section 6.3.2 that relates to whether or not a milestone event has been achieved shall be referred to the JSC to be resolved in accordance with Section 2.1.6.
Milestone Notices. Biotest shall provide ImmunoGen with prompt written notice upon each achievement of a milestone event set forth in Section 6.3.1, which notice shall include a description of the applicable milestone event. In the event that, notwithstanding the fact that Biotest has not given such a notice, ImmunoGen believes any such milestone event has occurred, it shall so notify Biotest in writing and shall provide to Biotest data, documentation or other information that supports its belief. Any dispute under this Section 6.3.2 that relates to whether or not a milestone event has been achieved shall be referred to the JSC to be resolved in accordance with Section 2.1.6. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934.